Continuing Clinical Push, Agilent Registers 1200 LC and 6000 Triple Quads with FDA
January 20, 2012
Continuing Clinical Push, Agilent Registers 1200 LC and 6000 Triple Quads with FDA
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Big Names Join Clinical Proteomics Push in 2011, Offering Ray of Optimism Amidst Difficult Year
January 6, 2012 / ProteoMonitor - Citing Disappointing Discovery Efforts, Researchers Look to Proteomics' Clinical Future
January 20, 2012 / ProteoMonitor - Agilent Partners with Integrated Diagnostics, Further Signaling Focus on MRM-MS as Clinical Platform
January 13, 2012 / ProteoMonitor - Thermo Fisher Achieves ISO 13485 Certification as Vendors Continue Prepping LC-MS for the Clinic
April 5, 2013 / ProteoMonitor - Agilent Inks Collaboration with Gachon University for Glycoprotein Biomarker Research
July 20, 2012 / ProteoMonitor